BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32562697)

  • 1. Granulomatosis with polyangiitis (Wegener's).
    Puéchal X
    Joint Bone Spine; 2020 Dec; 87(6):572-578. PubMed ID: 32562697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
    Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
    Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granulomatosis with polyangiitis (Wegener's granulomatosis)].
    Karras A; Guiard E; Lévi C; Thervet E
    Presse Med; 2012 Oct; 41(10):1014-23. PubMed ID: 22902722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncommon presentation of granulomatosis with polyangiitis: Prostate involvement.
    Jain N; Roy D; Mysore S; Negigowdru MM; Rao VKR
    Int J Rheum Dis; 2024 Jan; 27(1):e14831. PubMed ID: 37424167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Understanding and Unknown Aspects of the Treatment of Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Opportunities for Future Studies.
    Alesaeidi S; Darvishi M; Dabiri S; GhasemiAdl M; Jafarieh A; Tavakolpour S
    Curr Rheumatol Rev; 2020; 16(4):257-266. PubMed ID: 32228425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of non-identified ANCA (non-PR3, non-MPO) in the diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).
    Givaudan M; Vandergheynst F; Stordeur P; Ocmant A; Melot C; Gangji V; Soyfoo MS
    Acta Clin Belg; 2017 Oct; 72(5):313-317. PubMed ID: 28067125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients.
    Thai LH; Charles P; Resche-Rigon M; Desseaux K; Guillevin L
    Autoimmun Rev; 2014 Mar; 13(3):313-8. PubMed ID: 24225075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
    Cabral DA; Canter DL; Muscal E; Nanda K; Wahezi DM; Spalding SJ; Twilt M; Benseler SM; Campillo S; Charuvanij S; Dancey P; Eberhard BA; Elder ME; Hersh A; Higgins GC; Huber AM; Khubchandani R; Kim S; Klein-Gitelman M; Kostik MM; Lawson EF; Lee T; Lubieniecka JM; McCurdy D; Moorthy LN; Morishita KA; Nielsen SM; O'Neil KM; Reiff A; Ristic G; Robinson AB; Sarmiento A; Shenoi S; Toth MB; Van Mater HA; Wagner-Weiner L; Weiss JE; White AJ; Yeung RS;
    Arthritis Rheumatol; 2016 Oct; 68(10):2514-26. PubMed ID: 27111558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis.
    Falde SD; Fussner LA; Tazelaar HD; O'Brien EK; Lamprecht P; Konig MF; Specks U
    Lancet Rheumatol; 2024 May; 6(5):e314-e327. PubMed ID: 38574742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Should Type of ANCA Guide the Treatment?
    Tesar V; Hruskova Z
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1519-1521. PubMed ID: 32471814
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.
    Puéchal X; Iudici M; Perrodeau E; Bonnotte B; Lifermann F; Le Gallou T; Karras A; Blanchard-Delaunay C; Quéméneur T; Aouba A; Aumaître O; Cottin V; Hamidou M; Ruivard M; Cohen P; Mouthon L; Guillevin L; Ravaud P; Porcher R; Terrier B;
    JAMA Netw Open; 2022 Nov; 5(11):e2243799. PubMed ID: 36441554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ANCA-associated vasculitides : State of the art].
    Hellmich B
    Z Rheumatol; 2019 Aug; 78(6):518-528. PubMed ID: 31028473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.